CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- 4 Grant or award Director acquired 5,600 shares (grant or award)
- 4 Grant or award Director acquired 5,600 shares (grant or award)
- 4 Gift President and CEO gave 25,000 shares (gift)
- 4/A Insider Changes in Ownership
- 4 Exercise or conversion Chief Commercial Officer acquired 29,427 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 458 shares at $25.91 ($11,867)
- 4 Open-market sale Chief Commercial Officer sold 426 shares at $25.91 ($11,038)
- 4 Open-market sale General Counsel sold 458 shares at $25.91 ($11,867)
- 4 Open-market sale President and CEO sold 1,132 shares at $25.91 ($29,330)
- 4 Open-market sale President and CEO sold 25,000 shares at an average $27.07 ($676,635)
- 4 Open-market sale President and CEO sold 25,000 shares at an average $25.11 ($627,696)
- 4 Open-market sale President and CEO sold 25,000 shares at an average $31.05 ($776,220)
- 4 Open-market sale Chief Commercial Officer sold 22,000 shares at an average $30.55 ($672,002)
- 4 Open-market sale Chief Financial Officer sold 6,000 shares at an average $31.71 ($190,255)
- 4 Open-market sale President and CEO sold 1,421 shares at $32.73 ($46,509)
- 4/A Open-market sale President and CEO sold 25,000 shares at an average $41.95 ($1,048,780)
- 4/A Open-market sale President and CEO sold 25,000 shares at an average $43.75 ($1,093,856)
- 4 Open-market sale General Counsel sold 383 shares at $32.73 ($12,536)
- 4 Open-market sale Chief Commercial Officer sold 355 shares at $32.73 ($11,619)
- 4 Open-market sale Chief Financial Officer sold 383 shares at $32.73 ($12,536)
Page 8 of 12 · 229 filings